Cargando…
Statin use and endometrial cancer risk: a meta-analysis
Several studies have evaluated the association between statin use and endometrial cancer risk. We carried out a meta-analysis of randomized controlled trials (RCTs) and non-randomized studies to evaluate the effect of statins on endometrial cancer risk. A comprehensive search of electronic databases...
Autores principales: | Yang, Jing, Zhu, Qiaoling, Liu, Qiao, Wang, Yingxia, Xie, Weimin, Hu, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617516/ https://www.ncbi.nlm.nih.gov/pubmed/28977956 http://dx.doi.org/10.18632/oncotarget.18658 |
Ejemplares similares
-
Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017) -
Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017) -
Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies
por: Yang, Keming, et al.
Publicado: (2017) -
Prevalence of statin intolerance: a meta-analysis( )
por: Bytyçi, Ibadete, et al.
Publicado: (2022) -
Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A
Systematic Review and Meta-Analysis
por: Chang, Yue, et al.
Publicado: (2020)